The Ensign Group Inc (ENSG)vsNewGenIvf Group Limited Class A Ordinary Shares (NIVF)
ENSG
The Ensign Group Inc
$203.89
+0.48%
HEALTHCARE · Cap: $11.85B
NIVF
NewGenIvf Group Limited Class A Ordinary Shares
$2.01
+18.24%
HEALTHCARE · Cap: $983,320
Smart Verdict
WallStSmart Research — data-driven comparison
The Ensign Group Inc generates 110442% more annual revenue ($5.06B vs $4.58M). ENSG leads profitability with a 6.8% profit margin vs 3.8%. ENSG earns a higher WallStSmart Score of 57/100 (C).
ENSG
Buy57
out of 100
Grade: C
NIVF
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-0.3%
Fair Value
$211.28
Current Price
$203.89
$7.39 premium
Margin of Safety
+100.0%
Fair Value
$3305.41
Current Price
$2.01
$3303.40 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 20.2% year-over-year
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
6.8% margin — thin
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 1.6% — below average capital efficiency
3.8% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : ENSG
The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 20.2% demonstrates continued momentum.
Bull Case : NIVF
The strongest argument for NIVF centers on Price/Book.
Bear Case : ENSG
The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.
Bear Case : NIVF
The primary concerns for NIVF are EPS Growth, Market Cap, Return on Equity. Thin 3.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
ENSG profiles as a growth stock while NIVF is a value play — different risk/reward profiles.
ENSG carries more volatility with a beta of 0.80 — expect wider price swings.
ENSG is growing revenue faster at 20.2% — sustainability is the question.
Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ENSG scores higher overall (57/100 vs 51/100) and 20.2% revenue growth. NIVF offers better value entry with a 100.0% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
The Ensign Group Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.
NewGenIvf Group Limited Class A Ordinary Shares
HEALTHCARE · MEDICAL CARE FACILITIES · USA
NewGenIvf Group Limited (NIVF) is a prominent provider in the reproductive health sector, specializing in advanced fertility solutions and innovative in vitro fertilization (IVF) services. The company is dedicated to enhancing success rates in assisted reproductive techniques and addresses the growing global demand for fertility treatments through a well-established network of clinics and strategic partnerships. Positioned for growth within a rapidly expanding market, NIVF is well-equipped to capitalize on emerging opportunities, reinforcing its commitment to helping individuals and couples realize their dreams of parenthood.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?